{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:12:58Z","timestamp":1791997978314,"version":"4.4.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Bam University of Medical Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-025-01346-1","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:23:27Z","timestamp":1766413407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating treatment outcomes across four substance use treatment settings: a 12-month longitudinal study in Iran"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2024-8866","authenticated-orcid":false,"given":"Saeid","family":"Mirzaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8009-470X","authenticated-orcid":false,"given":"Vahid","family":"Yazdi-Feyzabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2412-9277","authenticated-orcid":false,"given":"Mohammad Hossein","family":"Mehrolhassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5808-6503","authenticated-orcid":false,"given":"Nouzar","family":"Nakhaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3278-3647","authenticated-orcid":false,"given":"Nadia","family":"Oroomiei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"1346_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.115830","volume":"334","author":"L Leza","year":"2024","unstructured":"Leza L, Haro B, L\u00f3pez-Go\u00f1i JJ, et al. Substance use disorder and lifetime suicidal behaviour: a scoping review. Psychiatry Res. 2024;334:115830.","journal-title":"Psychiatry Res"},{"key":"1346_CR2","unstructured":"United Nations Office on Drugs and Crime. World Drug Report 2024. Vienna, 2024."},{"key":"1346_CR3","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1111\/add.16456","volume":"119","author":"T Carr","year":"2024","unstructured":"Carr T, Kilian C, Llamosas-Falc\u00f3n L, et al. The risk relationships between alcohol consumption, alcohol use disorder and alcohol use disorder mortality: a systematic review and meta-analysis. Addiction. 2024;119:1174\u201387.","journal-title":"Addiction"},{"key":"1346_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1146\/annurev-criminol-030421-040140","volume":"6","author":"M Gottschalk","year":"2023","unstructured":"Gottschalk M. The opioid crisis: the war on drugs is over. Long live the war on drugs. Annu Rev Criminol. 2023;6:363\u201398.","journal-title":"Annu Rev Criminol"},{"key":"1346_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/15504263.2023.2295416","volume":"20","author":"BS Israel","year":"2024","unstructured":"Israel BS, Belcher AM, Ford JD. A harm reduction framework for integrated treatment of co-occurring opioid use disorder and trauma-related disorders. J Dual Diagn. 2024;20:52\u201385.","journal-title":"J Dual Diagn"},{"key":"1346_CR6","doi-asserted-by":"crossref","unstructured":"Maarefvand M, Khubchandani J. Substance users\u2019 perspectives on recovery from addiction: a field study from Iran. J Psychosoc Rehabil Ment Health 2025; 1\u201312.","DOI":"10.1007\/s40737-025-00467-x"},{"key":"1346_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12954-024-01105-8","volume":"21","author":"S Perrin","year":"2024","unstructured":"Perrin S, Fillol A, Moriceau S, et al. Exploring and describing alcohol harm reduction interventions: a scoping review of literature from the past decade in the western world. Harm Reduct J. 2024;21:207.","journal-title":"Harm Reduct J"},{"key":"1346_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/10439463.2023.2267729","volume":"34","author":"M Bacon","year":"2024","unstructured":"Bacon M. From criminalisation to harm reduction? The forms and functions of police drug diversion in England and Wales. Policing Soc. 2024;34:105\u201323.","journal-title":"Policing Soc"},{"key":"1346_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12962-024-00517-4","volume":"22","author":"E Jozaghi","year":"2024","unstructured":"Jozaghi E. A new innovative method to measure the cost of war: future with fewer conflicts via harm reduction approaches. Cost Eff Resour Alloc. 2024;22:9.","journal-title":"Cost Eff Resour Alloc"},{"key":"1346_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12954-022-00612-w","volume":"19","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S, Yazdi-Feyzabadi V, Mehrolhassani MH, et al. Setting the policy agenda for the treatment of substance use disorders in Iran. Harm Reduct J. 2022;19:27.","journal-title":"Harm Reduct J"},{"key":"1346_CR11","unstructured":"Our World in Data. Global Burden of Disease. Our World in Data, 2024. https:\/\/ourworldindata.org\/grapher\/share-with-drug-use-disorders?tab=chart&country=~IRN. Accessed 1 Jan 2025."},{"key":"1346_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2024.102872","volume":"46","author":"K Danandeh","year":"2024","unstructured":"Danandeh K, Rasoulian P, Seyedmirzaei H, et al. Burden of alcohol use disorder and its consequences in Iran from 1990 to 2019: findings from the global burden of disease study. Prev Med Rep. 2024;46:102872.","journal-title":"Prev Med Rep"},{"key":"1346_CR13","unstructured":"Iran Drug Control Headquarters. Set of executive regulations and guidelines for establishing, managing and supervising of govermental authorized centers, nongovernmental or private centers and non govermental organization for withdraw and harm reduction drug misuse. Tehran; 2010."},{"key":"1346_CR14","unstructured":"Center for the Prevention and Treatment of Addiction of State Welfare Organization of Iran. Comprehensive document on social protection and addiction treatment; 2013 (In Persian)."},{"key":"1346_CR15","unstructured":"Iran Drug Control Headquarters. Implementing regulations of the centers for the care, withdraw and harm reduction of drug misusers Subject to act 16 of the war on drugs Law. Tehran; 2014."},{"key":"1346_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2024.104325","volume":"124","author":"N Nakhaee","year":"2024","unstructured":"Nakhaee N, Karamouzian M, Sharifi H, et al. The effectiveness of court-mandated compulsory treatment in promoting abstinence among people with substance use disorders in Iran. Int J Drug Policy. 2024;124:104325.","journal-title":"Int J Drug Policy"},{"key":"1346_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13722-024-00511-4","volume":"19","author":"S Mirzaei","year":"2024","unstructured":"Mirzaei S, Yazdi-Feyzabadi V, Mehrolhassani MH, et al. Unveiling the roadblocks: exploring substance use disorder treatment policies in Iran through a qualitative lens. Addict Sci Clin Pract. 2024;19:80.","journal-title":"Addict Sci Clin Pract"},{"key":"1346_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12954-025-01226-8","volume":"22","author":"S Mirzaei","year":"2025","unstructured":"Mirzaei S, Yazdi-Feyzabadi V, Mehrolhassani MH, et al. Characterizing substance users and risk profiles across treatment centers: insights from Iran. Harm Reduct J. 2025;22:79.","journal-title":"Harm Reduct J"},{"key":"1346_CR19","doi-asserted-by":"publisher","first-page":"16819","DOI":"10.1038\/s41598-024-66257-w","volume":"14","author":"A Hajebi","year":"2024","unstructured":"Hajebi A, Nasserinejad M, Rezaei N, et al. Alcohol consumption among Iranian population based on the findings of STEPS survey 2021. Sci Rep. 2024;14:16819.","journal-title":"Sci Rep"},{"key":"1346_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10389-020-01412-x","volume":"31","author":"M Barati","year":"2023","unstructured":"Barati M, Bashirian S, Mohammadi Y, et al. An ecological approach to exploring factors affecting substance use relapse: a systematic review. J Public Health. 2023;31:135\u201348.","journal-title":"J Public Health"},{"key":"1346_CR21","unstructured":"Bagheri F, Ramezani M, Boskabadi H, et al. Experiences of mothers with substance use in the care of children in the first year of life: a qualitative content analysis. Int J Community Based Nurs Midwifery."},{"key":"1346_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0256563","volume":"16","author":"Y Rostam-Abadi","year":"2021","unstructured":"Rostam-Abadi Y, Gholami J, Amin-Esmaeili M, et al. Evidence for an increase in cannabis use in Iran\u2013a systematic review and trend analysis. PLoS ONE. 2021;16:e0256563.","journal-title":"PLoS ONE"},{"key":"1346_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.885","volume":"5","author":"J Hosseini","year":"2022","unstructured":"Hosseini J, Shojaeefar E, Pooladgar P, et al. Prevalence of substance use among Iranian male adolescents: systematic review and meta-analysis. Health Sci Rep. 2022;5:e885.","journal-title":"Health Sci Rep"},{"key":"1346_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.29252\/jnkums.6.1.189","volume":"6","author":"M Norouzi khalili","year":"2014","unstructured":"Norouzi khalili M, Hojjat S, Khajedaluee M, et al. Social, economical and population characteristics of substance dependents treated in North Khorasan drug rehabilitation centers. JNKUMS. 2014;6:189\u201397.","journal-title":"JNKUMS"},{"key":"1346_CR25","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1046\/j.1360-0443.1998.9312185711.x","volume":"93","author":"J Marsden","year":"1998","unstructured":"Marsden J, Gossop M, Stewart D, et al. The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction. 1998;93:1857\u201367.","journal-title":"Addiction"},{"key":"1346_CR26","unstructured":"Afshari R, Zare I, Moein L, et al. The effect of group schema therapy approach in improvement of b category personality disorders for substance dependent."},{"key":"1346_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.15171\/ijhpm.2013.24","volume":"1","author":"N Sadir","year":"2013","unstructured":"Sadir N, Shojaei M, Moadab K, et al. Outcome evaluation of therapeutic community model in Iran. Int J Health Policy Manag. 2013;1:131\u20135.","journal-title":"Int J Health Policy Manag"},{"key":"1346_CR28","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S2215-0366(23)00095-0","volume":"10","author":"L Degenhardt","year":"2023","unstructured":"Degenhardt L, Clark B, Macpherson G, et al. Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies. Lancet Psychiatry. 2023;10:386\u2013402.","journal-title":"Lancet Psychiatry"},{"key":"1346_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1080\/07347324.2019.1672600","volume":"38","author":"R Mamat","year":"2020","unstructured":"Mamat R, Nasrulddin NAA, Yusoff NAM. Continued use of illicit substance among methadone treatment patients in primary health care clinics in East Coast region of Malaysia. Alcohol Treat Q. 2020;38:184\u201398.","journal-title":"Alcohol Treat Q"},{"key":"1346_CR30","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","volume":"78","author":"T Santo","year":"2021","unstructured":"Santo T, Clark B, Hickman M, et al. Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis. JAMA Psychiatr. 2021;78:979\u201393.","journal-title":"JAMA Psychiatr"},{"key":"1346_CR31","unstructured":"Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. bmj; 357."},{"key":"1346_CR32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1046\/j.1360-0443.2003.00296.x","volume":"98","author":"M Gossop","year":"2003","unstructured":"Gossop M, Marsden J, Stewart D, et al. The national treatment outcome research study (NTORS): 4\u20135 year follow-up results. Addiction. 2003;98:291\u2013303.","journal-title":"Addiction"},{"key":"1346_CR33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.26719\/2025.31.6.357","volume":"31","author":"H Balkhy","year":"2025","unstructured":"Balkhy H. Strengthening public health response to substance use in the Eastern Mediterranean Region. East Mediterr Health J. 2025;31:357\u20138.","journal-title":"East Mediterr Health J"},{"key":"1346_CR34","volume-title":"Global status report on alcohol and health and treatment of substance use disorders","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Global status report on alcohol and health and treatment of substance use disorders. World Health Organization; 2024."},{"key":"1346_CR35","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00127-023-02587-w","volume":"59","author":"A Amirkafi","year":"2024","unstructured":"Amirkafi A, Mohammadi F, Tehrani-Banihashemi A, et al. Drug-use disorders in the Eastern Mediterranean Region: a glance at GBD 2019 findings. Soc Psychiatry Psychiatr Epidemiol. 2024;59:1113\u201327.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"1346_CR36","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/psychiatryint5030025","volume":"5","author":"NS Ganesh","year":"2024","unstructured":"Ganesh NS, Kaur M, Abd Rashid R, et al. Positive emotions and quality of life among Malaysian patients on methadone maintenance therapy and their psychosocial correlates. Psychiatry Int. 2024;5:360\u20139.","journal-title":"Psychiatry Int"},{"key":"1346_CR37","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/14659891.2023.2261055","volume":"29","author":"L Razeghian Jahromi","year":"2024","unstructured":"Razeghian Jahromi L, Sadeghi Mazidi S, Javid M, et al. Relationship between substance use-associated stigma and executive dysfunction. J Subst Use. 2024;29:881\u20135.","journal-title":"J Subst Use"},{"key":"1346_CR38","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13722-024-00472-8","volume":"19","author":"M Khazaee-Pool","year":"2024","unstructured":"Khazaee-Pool M, Naghibi SA, Pashaei T, et al. Developing practical strategies to reduce addiction-related stigma and discrimination in public addiction treatment centers: a mixed-methods study protocol. Addict Sci Clin Pract. 2024;19:40.","journal-title":"Addict Sci Clin Pract"},{"key":"1346_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e15566","author":"E Razaghi","year":"2023","unstructured":"Razaghi E, Farhoudian A, Pilevari A, et al. Identification of the socio-cultural barriers of drug addiction treatment in Iran. Heliyon. 2023. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15566.","journal-title":"Heliyon"},{"key":"1346_CR40","first-page":"307","volume":"5","author":"M Shahzadi","year":"2023","unstructured":"Shahzadi M, Riaz M, Imtiaz M, et al. Exploring stigma among patients with substance use disorders: a systematic review. IUB J Soc Sci. 2023;5:307\u201317.","journal-title":"IUB J Soc Sci"},{"key":"1346_CR41","first-page":"1","volume":"5","author":"H Ziaaddini","year":"2013","unstructured":"Ziaaddini H, Ebrahim-Nejad B, Nakhaee N. The effectiveness of group therapy on the family functioning of individuals under methadone treatment: a clinical trial. Addict Health. 2013;5:1.","journal-title":"Addict Health"},{"key":"1346_CR42","unstructured":"Iran Drug Control Headquarters Secretariat. Guidelines for policies and approaches to the treatment of stimulants drug abuse and addiction in Iran. Tehran; 2011."},{"key":"1346_CR43","unstructured":"Burkinshaw P, Knight J, Anders P, et al. An evidence review of the outcomes that can be expected of drug misuse treatment in England. Public Health England."},{"key":"1346_CR44","unstructured":"Statistical Centre of Iran. Employment time series. Tehran; 2019."},{"key":"1346_CR45","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12905-021-01390-6","volume":"21","author":"H Adelian","year":"2021","unstructured":"Adelian H, Khodabandeh Shahraki S, Miri S, et al. The effect of mindfulness-based stress reduction on resilience of vulnerable women at drop-in centers in the southeast of Iran. BMC Womens Health. 2021;21:255.","journal-title":"BMC Womens Health"},{"key":"1346_CR46","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.sbspro.2013.06.591","volume":"84","author":"H Sadeghi","year":"2013","unstructured":"Sadeghi H, Habibi Z, Haghrangbar F, et al. The effectiveness of harm reduction programs on reduce crimes of addicts referred the drop in centers (DIC). Procedia Soc Behav Sci. 2013;84:496\u2013500.","journal-title":"Procedia Soc Behav Sci"},{"key":"1346_CR47","doi-asserted-by":"publisher","DOI":"10.15171\/hpp.2019.34","volume":"9","author":"H Akbari","year":"2019","unstructured":"Akbari H, Roshanpajouh M, Nourijelyani K, et al. Profile of drug users in the residential treatment centers of Tehran, Iran. Health Promot Perspect. 2019;9:248.","journal-title":"Health Promot Perspect"},{"key":"1346_CR48","first-page":"66","volume":"9","author":"B Behzadi","year":"2022","unstructured":"Behzadi B, Hessam S, Vahdat S, et al. Performance management model of methadone maintenance treatment centers: challenges and strategies. Health Manag Inf Sci. 2022;9:66\u201375.","journal-title":"Health Manag Inf Sci"},{"key":"1346_CR49","unstructured":"Rafaiee R, Naqavi MR, Rezaiean L, et al. Quality of services in substance abuse treatment centers in Shahroud, Iran. Shahroud J Med Sci 2015; 8\u201311."},{"key":"1346_CR50","doi-asserted-by":"publisher","DOI":"10.17795\/ijpbs838","author":"L Sahebi","year":"2015","unstructured":"Sahebi L, Abadi MAJ, Mousavi SH, et al. Relationship between psychiatric distress and criminal history among intravenous drug abusers in Iran. Iran J Psychiatry Behav Sci. 2015. https:\/\/doi.org\/10.17795\/ijpbs838.","journal-title":"Iran J Psychiatry Behav Sci"},{"key":"1346_CR51","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jsat.2008.10.004","volume":"36","author":"JR McKay","year":"2009","unstructured":"McKay JR. Continuing care research: what we have learned and where we are going. J Subst Abuse Treat. 2009;36:131\u201345.","journal-title":"J Subst Abuse Treat"},{"key":"1346_CR52","doi-asserted-by":"crossref","unstructured":"Amrai F, Mahfoozpour S, Vahdat S, et al. Study of factors affecting the performance evaluation of Iranian health centers. J Biol Res-Bollettino della Societ\u00e0 Italiana di Biologia Sperimentale; 95.","DOI":"10.4081\/jbr.2022.10302"},{"key":"1346_CR53","first-page":"43","volume":"11","author":"M Amani","year":"2019","unstructured":"Amani M, Saemian H, Rezvan-Doust H. Comparison of residential and therapeutic community centers in preventing substance abuse recurrence and reducing self-destructive behaviors of substance users. Addict Health. 2019;11:43.","journal-title":"Addict Health"},{"key":"1346_CR54","doi-asserted-by":"publisher","first-page":"435","DOI":"10.32598\/irj.21.3.1625.1","volume":"21","author":"E Masoudnia","year":"2023","unstructured":"Masoudnia E. Effectiveness of addiction treatment programs in Iran in terms of social, psychological, economic, and therapeutic outcomes: an appraisal. Iran Rehabil J. 2023;21:435\u201350.","journal-title":"Iran Rehabil J"},{"key":"1346_CR55","doi-asserted-by":"publisher","DOI":"10.5812\/ijpbs.9892","author":"Z Alammehrjerdi","year":"2017","unstructured":"Alammehrjerdi Z, Massah O, Farhoudian A, et al. Therapeutic community program for opioid-dependent treatment seekers. Iran J Psychiatry Behav Sci. 2017. https:\/\/doi.org\/10.5812\/ijpbs.9892.","journal-title":"Iran J Psychiatry Behav Sci"},{"key":"1346_CR56","doi-asserted-by":"publisher","first-page":"203","DOI":"10.35335\/laweco.v17i3.45","volume":"17","author":"SR Shaver","year":"2023","unstructured":"Shaver SR, Forsyth O, Meritus D. Effectiveness of therapeutic community rehabilitation program for drug abuse in social institutions. Law Econ. 2023;17:203\u201317.","journal-title":"Law Econ"},{"key":"1346_CR57","unstructured":"Lameky VY. Substance use disorders treatment in therapeutic communities: a cross-cultural approach: By Miroslav Hor\u00e1k and Nahanga Verter, Switzerland. Cham: Springer; 2022. 463 Pages, eBook, $85, 59, ISBN 978-3-031-16459-0."},{"key":"1346_CR58","unstructured":"Hor\u00e1k M, Verter N. Substance use disorders treatment in therapeutic communities: a cross-cultural approach. Springer."},{"key":"1346_CR59","unstructured":"De Leon G. The therapeutic community: Study of effectiveness. US Department of Health and Human Services, Public Health Service, Alcohol\u2026, 1984."},{"key":"1346_CR60","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1111\/add.14905","volume":"115","author":"H Ekhtiari","year":"2020","unstructured":"Ekhtiari H, Noroozi A, Farhoudian A, et al. The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity? Addiction. 2020;115:1395\u2013403.","journal-title":"Addiction"},{"key":"1346_CR61","unstructured":"Iran Drug Control Headquarters. Regulations of authorized centers for withdraw and harm reduction of drug and psychoactive misuse, note 1 of article 15 amending the drug misuse law. Tehran, 2010."},{"key":"1346_CR62","doi-asserted-by":"crossref","unstructured":"Perfas FB, Casin-Romano SJ, Barcenas M, et al. An evaluation of therapeutic community in Malinao treatment and rehabiliation center under the Philippine Department of Health. In: The Therapeutic Community. Elsevier, p. 71\u2013110.","DOI":"10.1016\/B978-0-323-98816-2.00012-5"},{"issue":"1","key":"1346_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000331007","volume":"18","author":"M Malivert","year":"2011","unstructured":"Malivert M, Fats\u00e9as M, Denis C, et al. Effectiveness of therapeutic communities: a systematic review. Eur Addict Res. 2011;18(1):1\u201311.","journal-title":"Eur Addict Res"},{"key":"1346_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.602274","volume":"12","author":"K Kaikoushi","year":"2021","unstructured":"Kaikoushi K, Middleton N, Chatzittofis A, et al. Socio-demographic and clinical characteristics of adults with psychotic symptomatology under involuntary admission and readmission for compulsory treatment in a referral psychiatric hospital in Cyprus. Front Psychiatry. 2021;12:602274.","journal-title":"Front Psychiatry"},{"key":"1346_CR65","doi-asserted-by":"crossref","unstructured":"Russolillo A. A call for upstream solutions to the unregulated drug crisis in British Columbia, Canada: locked up or locked out. Can J Public Health 2025; 1\u20138.","DOI":"10.17269\/s41997-025-01065-x"},{"key":"1346_CR66","doi-asserted-by":"publisher","DOI":"10.1177\/00220426241231710","author":"J Jiang","year":"2024","unstructured":"Jiang J, Song A. Strong control and weak service: enforcing drug treatment in China. J Drug Issues. 2024. https:\/\/doi.org\/10.1177\/00220426241231710.","journal-title":"J Drug Issues"},{"key":"1346_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.103063","volume":"92","author":"J Yang","year":"2021","unstructured":"Yang J, Giummarra MJ. Compulsory and voluntary drug treatment models in China: a need for improved evidence-based policy and practice to reduce the loaded burden of substance use disorders. Int J Drug Policy. 2021;92:103063.","journal-title":"Int J Drug Policy"},{"key":"1346_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugpo.2015.12.005","volume":"28","author":"D Werb","year":"2016","unstructured":"Werb D, Kamarulzaman A, Meacham MC, et al. The effectiveness of compulsory drug treatment: a systematic review. Int J Drug Policy. 2016;28:1\u20139.","journal-title":"Int J Drug Policy"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01346-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01346-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01346-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T15:02:25Z","timestamp":1766415745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-025-01346-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1346"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01346-1","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"12 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This paper was approved by the Ethics Committee of Bam University of Medical Sciences, Iran (IR.MUBAM.REC.1404.005). All participants provided written informed consent. Authors are responsible for correctness of the statements provided in the manuscript. Authors have consented to the submission of the manuscript to the journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}